4 Pharma Firms Lose Licenses in Jammu and Kashmir Amid Illegal Drug Sales Crackdown
Authorities in Jammu and Kashmir have revoked the licenses of four pharmaceutical companies after uncovering their involvement in the secretive trade of addictive medications. Healthways Pharma (Rajouri), Nuegene Pharmaceutical Distributors, N T Traders (Baramulla), and Essence Pharmaceutical Distributors (Srinagar) were all penalized following a rigorous inspection by the State Drugs Controller-cum-Licensing Authority, Lotika Khajuria.
Investigators found these distributors were illegally purchasing and selling habit-forming drugs like Tapentadol and Pregabalin from neighboring states, while bypassing mandatory record-keeping requirements. This operation was described as a direct threat to public health and safety, particularly for vulnerable groups at risk of substance misuse.
Officials emphasized that any action facilitating prescription drug abuse will face the strictest penalties. The public is urged to report suspicious pharmaceutical activities to the authorities’ helpline. This decisive move highlights the government’s commitment to fighting illegal drug trade and protecting communities from the dangers of pharmaceutical misuse.
2026-10-04
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Univar Solutions Expands Partnership with American Distilling in EMEA to Strengthen Natural Specialty Ingredients Distribution Network
-
Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency
-
Wanhua’s Counter-Cyclical Expansion: A Gamble or a Strategic Move for the Next Cycle?
-
Is Evonik’s Massive Global Expansion of Hydroxyl-Terminated Polybutadiene (HTPB) a Technological Ambition — or a Geopolitical Gamble?
-
BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
US Chemical Shutdown Wave Expands, PS Units Become the Hardest Hit Segment
-
Covestro Builds New 660,000-ton MDI Plant in China: Global Supply Gap Meets Chinese Overcapacity Head-On
-
$2.43 Billion Deal: Olin Buys Huntsman
-
Advent Drops Its 2026 Purchase, and LANXESS’s €1.2 Billion Exit Plan Falls Through
Recommend Reading
-
Sinopec Oilfield Service Chairman Steps Down, Sinopec Shanghai Sales Branch Deputy GM Investigated on Consecutive Days
-
BASF Raises Acid Chloride and Chloroformate Capacity by 30% at Ludwigshafen
-
BASF Sues Apple Over Face Authentication Patents Used in Dozens of iPhones and iPads
-
Ineos Rescues UK's Last Dichloroethane Plant
-
Wanhua Chemical's Hungarian 650,000-ton MDI/TDI Plant to Shut Down for 35-Day Maintenance
-
Business Society’s Market Outlook for DOP on August 28, 2026: Stagnation and Bearish Alert
-
Business Society’s Market Outlook for Polyester Staple Fiber on August 31, 2026: Volatile
-
Insufficient cost support + weak demand: Melamine continues its weak consolidation
-
Business Society’s Market Outlook for Maleic Anhydride on August 27, 2026: Volatile
-
This week, caustic soda prices were consolidating (March 2-6)